Goldman Sachs’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.28M | Sell |
1,362,167
-52,705
| -4% | -$127K | ﹤0.01% | 3112 |
|
|
2025
Q1 | $3.13M | Sell |
1,414,872
-197,969
| -12% | -$438K | ﹤0.01% | 3074 |
|
|
2024
Q4 | $8.79M | Sell |
1,612,841
-425,707
| -21% | -$2.32M | ﹤0.01% | 2432 |
|
|
2024
Q3 | $16.9M | Buy |
2,038,548
+1,618,151
| +385% | +$13.4M | ﹤0.01% | 1850 |
|
|
2024
Q2 | $3.01M | Buy |
420,397
+221,130
| +111% | +$1.58M | ﹤0.01% | 2960 |
|
|
2024
Q1 | $1.73M | Sell |
199,267
-2,261
| -1% | -$19.6K | ﹤0.01% | 3287 |
|
|
2023
Q4 | $1.32M | Sell |
201,528
-39,774
| -16% | -$261K | ﹤0.01% | 3469 |
|
|
2023
Q3 | $2.41M | Buy |
241,302
+78,991
| +49% | +$790K | ﹤0.01% | 2984 |
|
|
2023
Q2 | $2.02M | Sell |
162,311
-215,542
| -57% | -$2.68M | ﹤0.01% | 3195 |
|
|
2023
Q1 | $5.29M | Sell |
377,853
-589,443
| -61% | -$8.26M | ﹤0.01% | 2497 |
|
|
2022
Q4 | $13.8M | Buy |
967,296
+587,745
| +155% | +$8.41M | ﹤0.01% | 1881 |
|
|
2022
Q3 | $9.69M | Buy |
379,551
+54,277
| +17% | +$1.39M | ﹤0.01% | 2148 |
|
|
2022
Q2 | $9.24M | Buy |
325,274
+41,846
| +15% | +$1.19M | ﹤0.01% | 2203 |
|
|
2022
Q1 | $10M | Sell |
283,428
-31,871
| -10% | -$1.12M | ﹤0.01% | 2243 |
|
|
2021
Q4 | $13.2M | Buy |
315,299
+195,439
| +163% | +$8.19M | ﹤0.01% | 2067 |
|
|
2021
Q3 | $5.88M | Sell |
119,860
-17,168
| -13% | -$843K | ﹤0.01% | 2675 |
|
|
2021
Q2 | $5.72M | Buy |
137,028
+6,800
| +5% | +$284K | ﹤0.01% | 2680 |
|
|
2021
Q1 | $4.64M | Buy |
130,228
+43,659
| +50% | +$1.56M | ﹤0.01% | 2723 |
|
|
2020
Q4 | $2.43M | Buy |
+86,569
| New | +$2.43M | ﹤0.01% | 2954 |
|